Literature DB >> 32966197

Trends in Use of Postdischarge Intravenous Antibiotic Therapy for Children.

Michael E Fenster1, Adam L Hersh1, Rajendu Srivastava1,2, Ron Keren3, Jacob Wilkes2, Eric R Coon1.   

Abstract

Children with complicated appendicitis, osteomyelitis, and complicated pneumonia have historically been treated with postdischarge intravenous antibiotics (PD-IV) using peripherally inserted central catheters (PICCs). Recent studies have shown no advantage and increased complications of PD-IV, compared with oral therapy, and the extent to which use of PD-IV has since changed for these conditions is not known. We used a national children's hospital database to evaluate trends in PD-IV during 2000-2018 for each of these three conditions. PD-IV decreased from 13% to 2% (risk ratio [RR], 0.15; 95% CI, 0.14-0.16) for complicated appendicitis, 61% to 22% (RR, 0.41; 95% CI, 0.39-0.43) for osteomyelitis, and 29% to 19% (RR, 0.63; 95% CI, 0.58-0.69) for complicated pneumonia. Despite these overall reductions, substantial variation in PD-IV use by hospital remains in 2018.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32966197      PMCID: PMC9514303          DOI: 10.12788/jhm.3422

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.899


  17 in total

1.  Pediatric hospitalists: a systematic review of the literature.

Authors:  Christopher P Landrigan; Patrick H Conway; Sarah Edwards; Rajendu Srivastava
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

2.  Conceptualizing De-Implementation in Cancer Care Delivery.

Authors:  Wynne E Norton; David A Chambers; Barnett S Kramer
Journal:  J Clin Oncol       Date:  2018-11-08       Impact factor: 44.544

3.  Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy.

Authors:  Nathan M Krah; Tyler Bardsley; Richard Nelson; Lawanda Esquibel; Mark Crosby; Carrie L Byington; Andrew T Pavia; Adam L Hersh
Journal:  Hosp Pediatr       Date:  2019-04

4.  Risk factors for peripherally inserted central venous catheter complications in children.

Authors:  Ketan Jumani; Sonali Advani; Nicholas G Reich; Leslie Gosey; Aaron M Milstone
Journal:  JAMA Pediatr       Date:  2013-05       Impact factor: 16.193

5.  A Multicenter Collaborative to Reduce Unnecessary Care in Inpatient Bronchiolitis.

Authors:  Shawn L Ralston; Matthew D Garber; Elizabeth Rice-Conboy; Grant M Mussman; Kristin A Shadman; Susan C Walley; Elizabeth Nichols
Journal:  Pediatrics       Date:  2015-12-01       Impact factor: 7.124

Review 6.  Pediatric hospital medicine: historical perspectives, inspired future.

Authors:  Erin Stucky Fisher
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2012-05

7.  Intravenous Versus Oral Antibiotics for Postdischarge Treatment of Complicated Pneumonia.

Authors:  Samir S Shah; Rajendu Srivastava; Susan Wu; Jeffrey D Colvin; Derek J Williams; Shawn J Rangel; Waheeda Samady; Suchitra Rao; Christopher Miller; Cynthia Cross; Caitlin Clohessy; Matthew Hall; Russell Localio; Matthew Bryan; Gong Wu; Ron Keren
Journal:  Pediatrics       Date:  2016-11-17       Impact factor: 7.124

8.  Intravenous Versus Oral Antibiotics for the Prevention of Treatment Failure in Children With Complicated Appendicitis: Has the Abandonment of Peripherally Inserted Catheters Been Justified?

Authors:  Shawn J Rangel; Brett R Anderson; Rajendu Srivastava; Samir S Shah; Paul Ishimine; Mythili Srinivasan; Matthew Bryan; Wu Gong; Matt Hall; Russell Localio; Xianqun Luan; Seema Anandalwar; Ron Keren
Journal:  Ann Surg       Date:  2017-08       Impact factor: 12.969

9.  Shortened IV Antibiotic Course for Uncomplicated, Late-Onset Group B Streptococcal Bacteremia.

Authors:  Eric R Coon; Raj Srivastava; Greg Stoddard; Jacob Wilkes; Andrew T Pavia; Samir S Shah
Journal:  Pediatrics       Date:  2018-10-11       Impact factor: 7.124

Review 10.  Towards understanding the de-adoption of low-value clinical practices: a scoping review.

Authors:  Daniel J Niven; Kelly J Mrklas; Jessalyn K Holodinsky; Sharon E Straus; Brenda R Hemmelgarn; Lianne P Jeffs; Henry Thomas Stelfox
Journal:  BMC Med       Date:  2015-10-06       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.